Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2021 Jul 5;40:223. doi: 10.1186/s13046-021-02028-z

Correction to: A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma

Bo Zhou 1, Hongxu Chen 1, Dong Wei 1, Yi Kuang 1, Xiaobiao Zhao 1, Guangyao Li 1, Jun Xie 1, Ping Chen 1,
PMCID: PMC8259138  PMID: 34225763

Correction to: J Exp Clin Cancer Res 33, 55 (2014)

https://doi.org/10.1186/1756-9966-33-55

Following publication of the original article [1], the authors identified minor errors in image-typesetting in Fig. 2; specifically, in Fig. 2D, the ‘97-h’ panel (top left) has been replaced by the correct image.

Fig. 2.

Fig. 2

SMC4 tumor-promoting effects (× 400). A Colony formation in soft agar after exposure to SMC4-homo-830. Representative images were taken at time 72 h after transfection. B Cell growth rates after exposure to SMC4-homo-830 as detected by WST-1 assay. C Wound-healing assays and cell motility after exposure to SMC4-homo-830. Representative images were taken at time 72 h after scratching. D SMC4-homo-830 decreased tumor cell invasion activity of 97-H and HepG2 cells. (*p < 0.05)

The corrected figure is provided here. The corrections do not have any effect on the results or conclusions of the paper. The original article has been corrected.

Reference

  • 1.Zhou B, Chen H, Wei D, et al. A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2014;33:55. doi: 10.1186/1756-9966-33-55. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES